Showing results (1021-1030 of 1,603) with videos related to

Sort By:
Pageof 161
RSC Medicinal Chemistry|October 22, 2025
Sequence-controlled peptoid hydrogels for neuronal trans-differentiation: a synthetic biomaterials approach in future neuroregenerative researchDeviramma C Yamanur, Pratikshya Paudel, Prabir Kumar Gharai
RSC Medicinal Chemistry|October 20, 2025
Design and synthesis of enantiopure NHC-silver(i) and NHC-gold(i) complexes with anticancer, anti-inflammatory and antioxidant propertiesDomenico Iacopetta, Assunta D'Amato, Jessica Ceramella, et al.
RSC Medicinal Chemistry|October 20, 2025
Structure-activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of mycetomaHung Phat Duong, Dmitrij Melechov, Wilson Lim, et al.
RSC Medicinal Chemistry|July 21, 2025
Discovery of semisynthetic derivatives of (R)- and (S)-usnic acids as potential antifungal agents against C. tropicalis and T. rubrumAnna Fontana, Alessio Colleoni, Roberta Listro, et al.
RSC Medicinal Chemistry|July 23, 2025
Computer-aided repositioning and functional in vitro assessment of novel PAD4 inhibitorsSofía Ruiz-Hernández, Fátima de Lourdes Ochoa-González, Julio E Castañeda-Delgado, et al.
RSC Medicinal Chemistry|July 14, 2025
A glimpse into the developments, potential leads and future perspectives of anticancer cobalt complexesAzharudin Khursheed, Nuzhat Khursheed, Nusrat Rashid, et al.
RSC Medicinal Chemistry|July 25, 2025
Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibit in vitro cytotoxic activity against cervical cancer and melanoma cellsDaniel Alejandro Castellar-Almonacid, Andrea Carolina Barragán-Cárdenas, Karla Geraldine Rodríguez-Mejia, et al.
RSC Medicinal Chemistry|July 9, 2025
A momentous progress update: epidermal growth factor receptor inhibitors as viable agents for combating cancerNeha Jangra, Bharti Sharma, Deepak Kumar, et al.
RSC Medicinal Chemistry|July 4, 2025
Design, synthesis and characterization of novel pyridazin-3-one derivatives: in vitro vasorelaxant activity and in silico insights into eNOS modulationMarian W Aziz, Khaled O Mohamed, Amira Karam Khalifa, et al.
RSC Medicinal Chemistry|July 9, 2025
Novel mangiferin derivatives attenuate adipogenesis in 3T3-L1 preadipocytes and ameliorate diet induced obesity in C57BL/6J miceDong-Quan Gu, Yin Li, Liu-Shun Wu, et al.
Pageof 161